Company Filing History:

9 out of 6,662

Hoechst Aktiengesellschaft

patents

1 out of 4

Hoescht Aktiengesellschaft

patents

Years Active: 1991-2002

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6348312 - Stabilized oligonucleotides and their use (2002-02-19),

2. 6033909 - Oligonucleotide analogs, their preparation and use (2000-03-07),

3. 5646261 - 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, (1997-07-08),

4. 5631259 - Cycloalkltriols containing cyclic substituents, processes and (1997-05-20),

5. 5563050 - Antisense oligonucleotides against HSV 1, and their preparation (1996-10-08),

6. 5459141 - Compounds 31668P and 31668U, a process for their production and their use (1995-10-17),

7. 5457091 - N1-substituted 1H-1,2,3-triazolo[4,5,-D]pyrimidines, a process for their (1995-10-10),

8. 5278152 - 2-formylbenzylphosphonic acid derivatives useful for the treatment of (1994-01-11),

9. 5242908 - Use of benzylphosphonic acid derivatives for the treatment of diseases (1993-09-07),

10. 5055457 - Pharmaceutical combinations product and the preparation and use thereof (1991-10-08),

Title: Matthias Helsberg: Innovator in Oligonucleotide Technology

Introduction

Matthias Helsberg is a prominent inventor based in Kelkheim, Germany. He has made significant contributions to the field of oligonucleotide technology, holding a total of 10 patents. His work focuses on the development of novel compounds that have important applications in diagnostics and therapeutics.

Latest Patents

Helsberg's latest patents include "Stabilized oligonucleotides and their use," which relates to innovative stabilized oligonucleotides modified with non-terminal pyrimidine nucleosides. These compounds are designed for use as diagnostics or pharmaceuticals in treating viral infections, cancer, and diseases involving integrins or cell-cell adhesion receptors. Another notable patent is "Oligonucleotide analogs, their preparation and use," which describes a range of compounds with specific chemical structures that serve as inhibitors of gene expression and probes for detecting nucleic acids.

Career Highlights

Throughout his career, Matthias Helsberg has worked with notable companies, including Hoechst Aktiengesellschaft. His expertise in oligonucleotide chemistry has positioned him as a key figure in the development of therapeutic solutions.

Collaborations

Helsberg has collaborated with esteemed colleagues such as Irvin Winkler and Anuschirwan Peyman, contributing to advancements in molecular biology and related fields.

Conclusion

Matthias Helsberg's innovative work in oligonucleotide technology has led to significant advancements in diagnostics and therapeutics. His contributions continue to impact the scientific community and improve treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.